Evidence map›Paper›PMID 39519299›Full record

ArticleInternational journal of molecular sciences2024

Leucine-Enriched Diet Reduces Fecal MPO but Does Not Protect Against DSS Colitis in a Mouse Model of Crohn's Disease-like Ileitis.

Drishtant Singh, Paola Menghini, Alexander Rodriguez-Palacios, Luca Di Martino, Fabio Cominelli, Abigail Raffner Basson

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Drishtant SinghDepartment of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0003-0179-2057
Paola MenghiniDivision of Gastroenterology & Liver Diseases, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-8779-088X
Alexander Rodriguez-PalaciosDivision of Gastroenterology & Liver Diseases, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0003-0713-5605
Luca Di MartinoCase Digestive Health Research Institute, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Fabio CominelliDivision of Gastroenterology & Liver Diseases, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.
Abigail Raffner BassonDepartment of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, OH 44106, USA.ORCID 0000-0002-8369-919X

Funding

Ubiquitination Pathways Mediating Chronic Intestinal InflammationP01DK091222 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI RODRIGUEZ-PALACIOS, ALEXANDER · 2011 to 2020
$16.5M
The Cleveland Digestive Diseases Research Core Center (DDRCC)P30DK097948 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI Fabio Cominelli · 2015 to 2026
$15.6M
MECHANISMS OF EXPERIMENTAL CROHNS DISEASER01DK055812 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI COMINELLI, FABIO · 1999 to 2019
$4.9M
CYTOKINES AND INFLAMMATORY BOWEL DISEASER01DK042191 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI COMINELLI, FABIO, PIZARRO, THERESA TORRES · 1995 to 2022
$4.7M
Effect of an Anti-Inflammatory Diet on Gut Homeostasis in Active and Experimental Crohn's DiseaseK01DK127008 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI RAFFNER, ABIGAIL · 2021 to 2025
$610k
Identification of Pathogenic Bacteria in Crohn's DiseaseR21DK118373 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI RODRIGUEZ-PALACIOS, ALEXANDER · 2018 to 2020
$601k
Mechanisms of Experimental Crohn's DiseaseR56DK055812 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI COMINELLI, FABIO, RODRIGUEZ-PALACIOS, ALEXANDER · 2021 to 2021
$403k
NIDDK NIH HHS K01 DK127008NIDDK NIH HHS P01 DK091222NIDDK NIH HHS P30 DK097948NIDDK NIH HHS R01 DK042191NIDDK NIH HHS R01 DK055812NIDDK NIH HHS R21 DK118373NIDDK NIH HHS R56 DK055812NIH HHS 1K01DK127008NIH HHS DK055812NIH HHS DK091222NIH HHS DK097948NIH HHS P01DK091222NIH HHS R21DK118373
6 · The paper itself

Abstract

Understanding the complex link between inflammation, gut health, and dietary amino acids is becoming increasingly important in the pathophysiology of inflammatory bowel disease (IBD). This study tested the hypothesis that a leucine-rich diet could attenuate inflammation and improve gut health in a mouse model of IBD. Specifically, we investigated the effects of a leucine-rich diet on dextran sulfate sodium (DSS)-induced colitis in germ-free (GF) SAMP1/YitFC (SAMP) mice colonized with human gut microbiota (hGF-SAMP). hGF-SAMP mice were fed one of four different diets: standard mouse diet (CHOW), American diet (AD), leucine-rich AD (AD + AA), or leucine-rich CHOW diet (CH + AA). Body weight, myeloperoxidase (MPO) activity, gut permeability, colonoscopy scores, and histological analysis were measured. Mice on a leucine-rich CHOW diet showed a decrease in fecal MPO prior to DSS treatment as compared to those on a regular diet (

Indexed as

Crohn DiseaseDextran SulfateDisease Models, AnimalFecesIleitisLeucinePeroxidaseAnimalsColitisDietGastrointestinal MicrobiomeHumansMaleMiceDextran SulfateLeucinePeroxidaseanti-inflammatorydietDSS colitisleucineSAMP1/YitFC mice

Identifiers

PMID39519299
PMCPMC11545852

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.